![Jonathan Aballi, President and Chief Executive Officer. [NASDAQ XGN] at Exagen](https://exagen.wpenginepowered.com/wp-content/uploads/2022/11/John-A-Headshot.png){kind=small}
Agendia
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
22 Morgan, Irvine, California, 92618, Un...Phone Number
(888) 321-2732Website
www.agendia.comRevenue
$57.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
2
1
1
About Agendia
Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting-edge genomics platform for tumor gene expression profiling, the company's tests help physicians more accurately tailor cancer treatments. Agendia markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Established in 2003, Agendia is based in Irvine, California.Explore more
Agendia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Agendia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Agendia
Check out if Agendia is spiking on competitors!
Funding: Get notified immidiatlly once Agendia has new funding data
Check if Agendia has recently received funding, and reach out quickly before it becomes old news!
Agendia, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Agendia had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Agendia launches new products
Earning: See what the market has to say on Agendia recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Agendia
Compare insights from companies similar to Agendia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$60.1M
51-200
Private
$82M
2006
DV
Daniel VummagoniCorporate Development Senior VP & Chief Financial Officer
Company Profile Activity
Activity Insights
Agendia is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Agendia is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Agendia.
Agendia financials insights
Gather financial insights about Agendia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series D
$34M
2009
Series E
$23M
2012
Private Equity
$65M
2014
Other Financing Round
$20.9M
2018
Unspecified
$35M
2020
Debt
$2M
Agendia Tech Stack
A closer look at the technologies used by Agendia
Most Recent Scoops
New Hire
Executive Move
Chris Carr has recently joined the organization as Chief Financial Officer. Previously, Carr served as Chief Financial Officer for Evolve Biologics.
Executive Moves, New Hire
Person-Based
Person-Based
Award
Award, Healthcare Technology
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Agendia News & Media
Agendia Named 2025 “Best Overall Genomics Company” By MedTech Breakthrough
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and CompaniesAgendia Spotlights New Data on Genomic Testing at 26th American Society of Breast Surgeons Annual Meeting
IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc., announced today that new MammaPrint and BluePrint data and their ability to inform axillary surgery decisions in the neoadjuvant setting will be presented at the 26th American Society of Breast Surgeons Annual Meeting (ASBrS), taking place in Las Vegas, NV, April 30 – May 4, 2025. This conference brings together leading experts in breast surgery and research to discuss the latest advancements within the industry. Agendia will highlighMammaPrint® Reimbursement Indication Extended in Belgium
IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc. announced today that the National Institute for Sickness and Invalidity Insurance (INAMI-RIZIV) located in Brussels has expanded the reimbursement indication for MammaPrint® to include its use in the neoadjuvant setting, effective January 1, 2025. The genomic assay will now be available for full reimbursement for patients with HR+/HER2 negative early-stage breast cancer in both the pre- and postoperative settings, enabling testing on cAgendia, Inc. Provides Review of Successful 2024
IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Agendia®, Inc. today provided a topline review of the company’s key milestone achievements in 2024. These updates include significant inroads in expanding market access, product innovation, commercial growth, advancements in research, as well as key partnerships and awards. “In the past year, Agendia has made great progress in advancing the field of precision oncology and genomic testing. We have seen success across multiple aspects of our business,
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Agendia
Sign Up For FreeTo access detailed company insights
Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting-edge genomics platform for tumor gene expression profiling, the company's tests help physicians more accurately tailor cancer treatments. Agendia markets four products, with... Read More
